908 Devices Inc. (MASS) vs Oculis Holding AG (OCS)

A side-by-side comparison of 908 Devices Inc. and Oculis Holding AG across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — MASS vs OCS

growth of $100 · dividends reinvested · last 5y
MASS -65.9% (-19.4%/yr)OCS -11.8% (-2.5%/yr)OCS compounded faster over this window
0100200300Start $10020222023202420252026$34$88
MASS OCS

MASS vs OCS: by the numbers

  • •MASS is the larger company ($506M vs $499M market cap).
  • •Both run net losses; MASS's is the smaller (-56.68% vs -32724.20% net margin).

Metrics side by side

Valuation

MetricMASSOCS
P/S ratio8.311634.02
P/B ratio3.991.84
FCF yield0.10%N/A

Profitability

MetricMASSOCS
Gross margin49.79%0.00%
Operating margin-46.01%0.00%
Net margin-56.68%-32724.20%
ROE-27.20%-36.79%
ROIC-18.90%-39.63%

Growth (annualized)

MetricMASSOCS
Revenue CAGR (5Y)18.92%N/A
Total return CAGR (5Y)-17.66%-2.41%

Frequently asked

How have MASS and OCS total returns compared?
Over the past 5 years, MASS delivered -17.66% and OCS delivered -2.41% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.